Measurement of statin exposure in the absence of information on prescribed doses.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years.European journal of hospital pharmacy : science and practice · 2024
   Article
2. Initial statin dose after myocardial infarction and long-term cardiovascular outcomes.European heart journal. Cardiovascular pharmacotherapy · 2023
   Article
3. Statin discontinuation in persons with and without Alzheimer's disease.European journal of clinical pharmacology · 2022
   Article
4. Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status.Biomedicines · 2020
   Article
5. Methods for constructing treatment episodes and impact on exposure-outcome associations.European journal of clinical pharmacology · 2020
   Observational
6. Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease.Drugs & aging · 2019
   Article
7. Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study.British journal of clinical pharmacology · 2019
   Article
8. Methods for time-varying exposure related problems in pharmacoepidemiology: An overview.Pharmacoepidemiology and drug safety · 2018
   Review
9. Drug exposure in register-based research-An expert-opinion based evaluation of methods.PloS one · 2017
   Article
10. Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.BMJ open · 2016
    Article
11. Childhood adversity as a predictor of non-adherence to statin therapy in adulthood.PloS one · 2015
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as